Lexaria Bioscience Corp.
(LEXX)
undefined
undefined%
At close: undefined
2.14
-4.42%
After-hours Dec 13, 2024, 04:57 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -5.81M | -6.71M | -7.38M | -4.19M | -4.08M | -4.16M | -6.61M | -1.93M | -1.28M | -1.93M | -343.55K | -251.51K | -538.23K | -552.46K | -753.57K | -978.49K | -1.06M | -508.26K | -75.72K |
| Depreciation & Amortization | 76.15K | 145.40K | 141.31K | 147.60K | 112.75K | 60.55K | 2.31K | 1.49K | 619.00 | - | - | 343.06K | 425.00 | 1.02K | 1.25K | 453.12K | 148.38K | 81.76K | - |
| Stock-Based Compensation | 492.24K | 170.38K | 752.59K | 410.01K | 1.14M | 626.69K | 2.60M | 113.04K | 122.02K | 256.05K | 820.89K | 21.28K | 11.34K | 179.79K | 161.37K | - | 75.47K | - | - |
| Other Working Capital | -684.36K | -14.84K | -262.73K | -234.89K | -24.96K | 165.05K | -17.08K | -251.91K | 298.01K | 182.74K | 211.69K | 33.77K | -304.70K | -64.15K | 6.19K | -4.98K | - | - | 33.40K |
| Other Non-Cash Items | 174.71K | 530.35K | 1.96M | 92.91K | 100.00K | 234.50K | 781.06K | 208.78K | 79.50K | 223.00K | 362.36K | 457.68K | 15.71K | 156.57K | 444.56K | 510.94K | 708.53K | 264.86K | - |
| Deferred Income Tax | - | -158.10K | - | -517.57K | 230.33K | 151.43K | 1.08M | 361.36K | 76.29K | - | - | - | 423.02K | - | - | -33.13K | - | - | - |
| Change in Working Capital | 106.56K | 143.26K | -351.48K | 63.53K | -161.02K | 79.68K | -371.23K | -301.12K | 337.97K | -45.73K | 280.92K | -81.56K | -275.82K | -96.83K | 214.44K | 1.13K | -19.58K | 8.27K | 33.40K |
| Operating Cash Flow | -4.96M | -5.88M | -4.88M | -3.99M | -2.66M | -3.01M | -2.52M | -1.55M | -660.86K | -1.50M | 321.00K | 135.94K | -195.10K | -330.34K | -36.40K | 29.04K | -218.56K | -153.38K | -42.32K |
| Capital Expenditures | - | -169.61K | -131.45K | -79.49K | -33.65K | -769.16K | -85.40K | -9.70K | -20.10K | -36.99K | -91.61K | -274.13K | -697.69K | -285.24K | -223.83K | -582.43K | -2.09M | -1.53M | -259.18K |
| Acquisitions | - | - | - | 273.37K | - | - | -70.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | 6.80K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | -188.60K | -135.86K | -49.19K | 273.37K | -26.84K | -122.98K | -85.40K | -9.70K | -17.01K | 721.81K | 21.00K | 21.00K | -274.13K | -697.69K | -285.24K | 206.02K | -376.41K | - | - |
| Investing Cash Flow | -188.60K | -169.61K | -180.64K | 193.88K | -26.84K | -769.16K | -155.40K | -9.70K | -20.10K | 684.82K | -70.61K | -274.13K | -697.69K | -285.24K | -223.83K | -376.41K | -2.09M | -1.53M | -259.18K |
| Debt Repayment | - | - | - | -66.69K | -13.83K | - | - | -50.00K | 95.00K | -98.74K | - | -365.36K | 287.50K | 366.81K | 165.00K | -84.01K | 693.95K | 50.00K | 2.00M |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 6.11M | - | -44.60K | 4.02M | - | 1.00M | - | - | - | - | -365.36K | - | - | 457.29K | - | -182.25K | 245.00K | 1.00M | -939.94K |
| Financial Cash Flow | 10.32M | 1.59M | -44.60K | 13.42M | 2.70M | 3.33M | 1.87M | 4.00M | 514.29K | 373.25K | -365.36K | 287.50K | 861.00K | 348.40K | -79.24K | 938.95K | 1.10M | 2.10M | 1.17M |
| Net Cash Flow | 5.15M | -4.46M | -5.10M | 9.62M | 8.60K | -442.04K | -806.15K | 2.44M | -166.67K | -442.95K | -114.97K | 149.31K | -31.79K | -267.18K | -339.47K | 591.57K | -1.21M | 421.74K | 863.56K |
| Free Cash Flow | -4.96M | -6.05M | -5.01M | -4.07M | -2.70M | -3.77M | -2.60M | -1.56M | -680.96K | -1.54M | 229.39K | -138.19K | -892.79K | -615.58K | -260.23K | -553.40K | -2.31M | -1.68M | -301.50K |